Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists hunt for clues in breast cancer tissue to predict relapse

NCT ID NCT02050750

Knowledge-focused Sponsor: Cancer Trials Ireland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects and stores breast cancer tissue from 600 people who took part in the TAILORx trial. Researchers will analyze the samples to find biological markers that can predict if the cancer will come back or resist hormone therapy and chemotherapy. No new treatments are given; the goal is to better understand the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

600 people

The number who actually took part.

Started

Dec 2013

Expected to finish

Nov 2031

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist only of patients that participated in the TAILORx ICORG 06-31 trial. These patients must have participated in trial arms relevant to ICORG 06-31 study and have adequate tumour tissue available.

Ages

18 to 75 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients that were registered with the ICORG 06-31 TAILORx trial and participated in trial arms * Patients with adequate tumor tissue available

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

Contacts and locations

Locations

  • Adelaide and Meath National Children's Hospital Tallaght

    Dublin, 24, Ireland

  • Beaumont Hospital

    Dublin, 9, Ireland

  • Bons Secours Hospital

    Cork, Ireland

  • Cork University Hospital

    Cork, Ireland

  • Galway University Hospital

    Galway, Ireland

  • Letterkenny General Hospital

    Donegal, Ireland

  • Mater Misericordiae University Hospital

    Dublin, Ireland

  • Midwestern Regional Hospital

    Limerick, Ireland

  • Sligo General Hosptial

    Sligo, Ireland

  • St James Hospital

    Dublin, 8, Ireland

  • St Vincent Universtiy Hospital

    Dublin, 4, Ireland

  • Waterford Regional Hospital

    Waterford, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.